Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Онкологическая фотодинамическая терапия: основные принципы, текущее клиническое состояние и перспективы
2017-02-18
SCID: 54.1/zft83pdr
Discuss with AI
clinical trialsoncologic photodynamic therapyphotodynamic therapyphotosensitizerreactive oxygen species
Figures from the paper
Abstract (AI)
Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a photochemical reaction between a light activatable molecule or photosensitizer, light, and molecular oxygen. When these three harmless components are present together, reactive oxygen species are formed. These can directly damage cells and/or vasculature, and induce inflammatory and immune responses. PDT is a two-stage procedure, which starts with photosensitizer administration followed by a locally directed light exposure, with the aim of confined tumor destruction. Since its regulatory approval, over 30 years ago, PDT has been the subject of numerous studies and has proven to be an effective form of cancer therapy. This review provides an overview of the clinical trials conducted over the last 10 years, illustrating how PDT is applied in the clinic today. Furthermore, examples from ongoing clinical trials and the most recent preclinical studies are presented, to show the directions, in which PDT is headed, in the near and distant future. Despite the clinical success reported, PDT is still currently underutilized in the clinic. We also discuss the factors that hamper the exploration of this effective therapy and what should be changed to render it a more effective and more widely available option for patients.
Key Findings
1
Despite demonstrated clinical success, PDT remains underutilized in clinical practice due to identifiable limiting factors that need to be addressed to increase effectiveness and availability.
2
Ongoing clinical trials and recent preclinical studies indicate active directions for PDT development in the near and distant future.
3
Over the past 30+ years and especially in the last 10 years of clinical trials, PDT has proven to be an effective form of cancer therapy in clinical practice.
4
PDT is a clinically approved cancer therapy that relies on a photochemical reaction among a photosensitizer, light, and molecular oxygen to produce reactive oxygen species.
5
PDT is administered in two stages: photosensitizer administration followed by localized light exposure to achieve confined tumor destruction.
6
Reactive oxygen species generated by PDT can directly damage tumor cells and vasculature and trigger inflammatory and immune responses.
Research Object
Photodynamic therapy (PDT) for cancer treatment
Research Subject
Clinical application, efficacy, mechanisms (reactive oxygen species–mediated tumor and vascular damage, inflammatory and immune responses), current clinical status, barriers to wider adoption, and future directions of oncologic PDT
Publication Details
Publication Date
2017-02-18
Journal
Publisher
ISSN
Cited by
1014
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by4
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical2022
Derivatives of Natural Chlorophylls as Agents for Antimicrobial Photodynamic Therapy2021
Recent Advances in Self-Exciting Photodynamic Therapy2020
NIR-activated multifunctional agents for the combined application in cancer imaging and therapy2024